USE OF THYMOSIN IN HEPATITIS C TREATMENT IN RESPONSE TO INTERFERENCE TREATMENT

摘要

A method of treating Hepatitis C by administering an immune system-potentiating dose of at least one Thymosin or system-potentiating Thymosin fragment to a mammal infected with Hepatitis C virus, which Hepatitis C infection in the mammal is non-responsive to treatment with interferon alone.